SCHEMBL1489129

SCHEMBL1489129

CC(=O)N(O)[C@@H](C)C=Cc1cccc(Oc2ccc(F)cc2)c1

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 9/20 0.81
MAPT P10636 3/20 0.81
MEN1 O00255 2/20 0.81
KMT2A Q03164 2/20 0.81
CYP3A4 P08684 2/20 0.81
CYP2D6 P10635 2/20 0.81
CYP2C9 P11712 2/20 0.81
CYP2C19 P33261 2/20 0.81
ALDH1A1 P00352 1/20 0.81
TP53 P04637 1/20 0.81
CYP1A2 P05177 1/20 0.81
HPGD P15428 1/20 0.81
ALOX15 P16050 1/20 0.81
TSHR P16473 1/20 0.81
ALOX12 P18054 1/20 0.81
NFKB1 P19838 1/20 0.81
MAPK1 P28482 1/20 0.81
HIF1A Q16665 1/20 0.81
LMNA P02545 1/20 0.81
BLM P54132 1/20 0.81

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9781071 1.00 ALOX5 (0.81) ALOX5MAPTMEN1KMT2ACYP3A4
SCHEMBL10338645 1.00 ALOX5 (0.81) ALOX5MAPTMEN1KMT2ACYP3A4
SCHEMBL9781074 1.00 ALOX5 (0.81) ALOX5MAPTMEN1KMT2ACYP3A4
SCHEMBL6008832 0.90 ALOX5 (0.66) ALOX5MAPTMEN1KMT2ACYP3A4
SCHEMBL6008836 0.90 ALOX5 (0.66) ALOX5MAPTMEN1KMT2ACYP3A4
SCHEMBL6008840 0.90 ALOX5 (0.66) ALOX5MAPTMEN1KMT2ACYP3A4
SCHEMBL7716648 0.90 ALOX5 (1.00) ALOX5MAPTMEN1KMT2ACYP3A4
SCHEMBL2681955 0.90 ALOX5 (1.00) ALOX5MAPTMEN1KMT2ACYP3A4
SCHEMBL2681949 0.90 ALOX5 (1.00) ALOX5MAPTMEN1KMT2ACYP3A4
SCHEMBL9514428 0.90 ALOX5 (1.00) ALOX5MAPTMEN1KMT2ACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0351214-A1 Anti-inflammatory aryl derivatives THE WELLCOME FOUNDATION LIMITED (GB) 1990-01-17 EP claimed
JP-2088553-A None JP disclosed
US-20110077305-A1 5-LIPOXYGENASE INHIBITORS FYLOCEL LTD. (GB) 2011-03-31 US disclosed
EP-2299996-A1 5-LIPOXYGENASE INHIBITORS Jackson, William Paul (GB) 2011-03-30 EP disclosed
JP-H0288553-A ANTI-INFLAMMATORY ARYL DERIVATIVE WELLCOME FOUND LTD:THE 1990-03-28 JP disclosed
EP-0351214-A1 Anti-inflammatory aryl derivatives THE WELLCOME FOUNDATION LIMITED (GB) 1990-01-17 EP disclosed
EP-0351214-A1 Anti-inflammatory aryl derivatives THE WELLCOME FOUNDATION LIMITED (GB) 1990-01-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110077305-A1 5-LIPOXYGENASE INHIBITORS ALOX12, ALOX15, ALOX5 ALOX5 3/4885MAPT 4880/4885MEN1 3066/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.